Sort
64,565 grants matching “drug discovery”
CTSA K12 Program at the University of Alabama at Birmingham
$1,620,000Kenneth G Saag · University Of Alabama At Birmingham · K12 · FY2024 · TR
CTSA K12 Program at the University of Michigan
$1,620,000Vicki L Ellingrod · University Of Michigan At Ann Arbor · K12 · FY2023 · TR
CTSA K12 Program at the University of Michigan
$1,620,000Vicki L Ellingrod · University Of Michigan At Ann Arbor · K12 · FY2025 · TR
CTSA K12 Program at the University of Michigan
$1,620,000Vicki L Ellingrod · University Of Michigan At Ann Arbor · K12 · FY2024 · TR
Metabolomic Signatures for Disease Sub-classification and Target Prioritization in AMP-AD
$1,619,858Rima F Kaddurah-Daouk · Duke University · U01 · FY2021 · AG
NCTN BIQSFP ANBL1531 (NRT)
$1,619,532Douglas S. Hawkins · Public Health Institute · U10 · FY2023 · CA
Consortium for Translational Research in Marfan Syndrome
$1,619,172Francesco B Ramirez · Icahn School Of Medicine At Mount Sinai · P01 · FY2009 · AR
3D Bioprinting of human native-like tissues as disease-in-a-dish models for drug discovery
$1,618,900Marc Ferrer-Alegre · National Center For Advancing Translational Sciences · ZIA · FY2017 · TR
Calcium Signaling & Prefrontal Deficits in Schizophrenia
$1,618,751David A McCormick · Yale University · P50 · FY2008 · MH
Exploring how the genome folds through proximity ligation and sequencing
$1,618,451Erez Lieberman-Aiden · Broad Institute, Inc. · DP2 · FY2011 · OD
Medical Scientist Training Program
$1,618,270Christopher S. Williams · Vanderbilt University · T32 · FY2024 · GM
Illuminating the Druggable Genome Knowledge Management Center (IDG KMC)
$1,618,181Tudor I Oprea · University Of New Mexico Health Scis Ctr · U54 · FY2015 · CA
Novel therapies to inhibit diabetic retinopathy
$1,617,650Timothy S Kern · Case Western Reserve University · R24 · FY2016 · EY
Genetic Modifiers of Initiation and Progression of Mammary Cancer
$1,617,570Kent W Hunter · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Functional Analysis of Novel Genes in Eye Development and Vision
$1,616,650Graeme J Wistow · National Eye Institute · ZIA · FY2023 · EY
Novel therapies to inhibit diabetic retinopathy
$1,616,335Timothy S Kern · Case Western Reserve University · R24 · FY2017 · EY
Yale/NIDA Neuroproteomics Center
$1,616,094Kenneth Robert Williams · Yale University · P30 · FY2023 · DA
Yale/NIDA Neuroproteomics Center
$1,616,094Kenneth Robert Williams · Yale University · P30 · FY2021 · DA
Yale/NIDA Neuroproteomics Center
$1,616,094Kenneth Robert Williams · Yale University · P30 · FY2020 · DA
Yale/NIDA Neuroproteomics Center
$1,616,094Kenneth Robert Williams · Yale University · P30 · FY2022 · DA
Yale/NIDA Neuroproteomics Center
$1,616,094Kenneth Robert Williams · Yale University · P30 · FY2024 · DA
Pharmacogenomic Evaluation of Antihypertensive Responses
$1,614,979University Of Florida · U01 · FY2005 · GM
Reprogramming Plant Perception for Novel Plant Natural Products Discovery
$1,614,872Yanran Li · University Of California Riverside · DP2 · FY2020 · AT
TREAT AD Structural Biology Core
$1,614,658Allan I Levey · Emory University · U54 · FY2025 · AG
Rare & Mosaic Disorders Molecular Research
$1,613,771Leslie Biesecker · National Human Genome Research Institute · ZIA · FY2022 · HG